* Cyclo Therapeutics Inc CYTH.OQ CYTH.O is expected
to show a
rise in quarterly revenue when it reports results on May 10
(estimated).
* The Gainesville Florida Florida-based company is expected
to
report a 95.0% increase in revenue to $380 thousand from $194.9
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Cyclo Therapeutics
Inc is
for a loss of 42 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
This summary was machine generated May 8 at 11:02 GMT. All
figures in US dollars unless otherwise stated